GGrantIndex
← Leaderboards

Patrick Finan

University Of Virginia

$9,396,345
Attributed
$15,141,751
Total exposure
8
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $6M · FY201425
$10M$7.5M$5M$2.5M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$15,141,751 · 8

By mechanism

R01$5,636,549 · 2
U01$5,254,789 · 1
R33$1,518,560 · 1
R61$1,005,568 · 1
R21$888,250 · 2
K23$838,035 · 1

Top collaborators

Most similar at University Of Virginia

Same institution · by research overlap

Others in their field

Top investigators on “Affect

Research focus

AffectPainResponseBrainStimulusSleepAmericanSleep DisturbancesPatient Self-ReportAlzheimer&AposOpioidRewardsAttenuatedReportingBehavioralChronicParticipantSamplingAffectivePrimary OutcomeChronic PainLaboratoriesDoseRisk Factors

Grant awards (21)

An Adaptive Intervention to Improve Pain Outcomes Following Cognitive Behavioral Therapy for Insomnia in Patients with Comorbid Chronic Low Back Pain and Insomnia$817,330
R01 · FY2025 · AT · contact PI
Psilocybin and Affective Function in Chronic Lower Back Pain and Depression$511,903
R33 · FY2025 · AT
Effects of Sleep Disruption on Subjective Responses to Opioid Administration in Patients with Chronic Pain$796,909
R01 · FY2024 · DA
Evaluating the Role of the Orexin System in Circadian Rhythms of Sleep and Stress in Persons on Medication-Assisted Treatments for Opioid Use Disorder$623,135
U01 · FY2024 · HL
Psilocybin and Affective Function in Chronic Lower Back Pain and Depression$527,915
R33 · FY2024 · AT
Gut microbiome and blood indices in patients with AD and their spousal caregivers$201,875
R21 · FY2024 · AG · contact PI
Effects of Sleep Disruption on Subjective Responses to Opioid Administration in Patients with Chronic Pain$1,053,798
R01 · FY2023 · DA
Psilocybin and Affective Function in Chronic Lower Back Pain and Depression$478,742
R33 · FY2023 · AT
Exhaled volatile organic compounds, phospho-tau and postoperative delirium$444,125
R21 · FY2023 · AG · contact PI
Gut microbiome and blood indices in patients with AD and their spousal caregivers$242,250
R21 · FY2023 · AG · contact PI
Effects of Sleep Disruption on Subjective Responses to Opioid Administration in Patients with Chronic Pain$1,043,859
R01 · FY2021 · DA
Effects of Sleep Disruption on Subjective Responses to Opioid Administration in Patients with Chronic Pain$1,038,977
R01 · FY2020 · DA · contact PI
Separate and Combined Effects of Mindfulness Meditation and Savoring on Pain-Related Corticostriatal Function$479,204
R61 · FY2020 · AT · contact PI
Evaluating the Role of the Orexin System in Circadian Rhythms of Sleep and Stress in Persons on Medication-Assisted Treatments for Opioid Use Disorder$4,631,654
U01 · FY2019 · HL
Effects of Sleep Disruption on Subjective Responses to Opioid Administration in Patients with Chronic Pain$885,676
R01 · FY2019 · DA · contact PI
Separate and Combined Effects of Mindfulness Meditation and Savoring on Pain-Related Corticostriatal Function$526,364
R61 · FY2019 · AT · contact PI
Sleep disturbance as a putative mechanism for reward system dysfunction$167,607
K23 · FY2018 · DA · contact PI
Sleep disturbance as a putative mechanism for reward system dysfunction$167,607
K23 · FY2017 · DA · contact PI
Sleep disturbance as a putative mechanism for reward system dysfunction$167,607
K23 · FY2016 · DA · contact PI
Sleep disturbance as a putative mechanism for reward system dysfunction$167,607
K23 · FY2015 · DA · contact PI
Sleep disturbance as a putative mechanism for reward system dysfunction$167,607
K23 · FY2014 · DA · contact PI